Vashti C. Bryant, Ph.D. - Publications

2011 University of Texas Medical Branch, Galveston, TX 
Molecular Biology, Pharmaceutical Chemistry

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Radhakrishnan P, Bryant VC, Blowers EC, Rajule RN, Gautam N, Anwar MM, Mohr AM, Grandgenett PM, Bunt SK, Arnst JL, Lele SM, Alnouti Y, Hollingsworth MA, Natarajan A. Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2025-35. PMID 23444213 DOI: 10.1158/1078-0432.Ccr-12-2909  0.56
2012 Rajule R, Bryant VC, Lopez H, Luo X, Natarajan A. Perturbing pro-survival proteins using quinoxaline derivatives: a structure-activity relationship study. Bioorganic & Medicinal Chemistry. 20: 2227-34. PMID 22386982 DOI: 10.1016/J.Bmc.2012.02.022  0.56
2012 Bryant VC, Kishore Kumar GD, Nyong AM, Natarajan A. Synthesis and evaluation of macrocyclic diarylether heptanoid natural products and their analogs. Bioorganic & Medicinal Chemistry Letters. 22: 245-8. PMID 22137846 DOI: 10.1016/J.Bmcl.2011.11.025  0.56
2011 Chen Q, Bryant VC, Lopez H, Kelly DL, Luo X, Natarajan A. 2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study. Bioorganic & Medicinal Chemistry Letters. 21: 1929-32. PMID 21376584 DOI: 10.1016/J.Bmcl.2011.02.055  0.56
2011 Bryant VC, Radhakrishnan P, Hollingsworth MA, Natarajan A. Abstract LB-206: A novel scaffold that targets the IKK complex Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-206  0.56
Show low-probability matches.